Home›Companies›Biotech & Pharma›WayBio

Way Biosolutions, Inc.

WayBio builds and modifies DNA plasmids for research and biotechnology teams.

Updated Nov 9, 2026·Latest SEC filing Sep 25, 2026·Suggest an edit

About WayBio

WayBio is a private company based in Cambridge, Massachusetts, incorporated in 2024 in Delaware. It has reported $2,000,000 raised in one offering on Form D since September 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 14, 2025Sep 25, 2026$2,000,000fully sold2$1.0MSecurities on exercise, Simple Agreement for Future EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on WayBio's Form D filed Sep 25, 2026.

Huaibin Zhang
Huaibin Zhang
Member of the Board
Paul Meister
Paul Meister
Member of the Board
David Walt
David Walt
Member of the Board

Sources

  1. SECWay Biosolutions, Inc. filing history
  2. CompanyWayBio about